Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

The findings highlight the early postpartum period as a potential window of opportunity to improve long-term brain health in ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...

At its core, conservation is about behavior change. Yet few organizations have put in place the structure, standards, and ...

In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...

A systematic review and meta-analysis of 15 studies found that ketogenic diets were associated with short-term reductions in ...

Artificial sweeteners have long been cast as either miracle weight-loss allies or metabolic saboteurs — but the science is ...

Detailed price information for Processa Pharmaceuticals Inc (PCSA-Q) from The Globe and Mail including charting and trades.

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...

It wasn't exactly a surprise after months of leaks and speculation, but Nvidia CEO Jensen Huang (in perhaps his finest ...